XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS SEGMENT
 9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
BUSINESS SEGMENT BUSINESS SEGMENT
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision making group, in deciding how to allocate resources and in assessing performance. We have one operating and reporting segment, OrthoPediatrics Corp., which designs, develops and markets anatomically appropriate implants and devices for children with orthopedic problems. Our chief operating decision-maker, our Chief Executive Officer, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance, accompanied by disaggregated revenue information by product category. We determined that disaggregating revenue into these categories achieves the disclosure objective of illustrating the differences in the nature, timing and uncertainty of our revenue streams. We do not assess the performance of our individual product categories on measures of profit or loss, or other asset-based metrics. Therefore, the information below is presented only for revenue by category and geography.

Product sales attributed to a country or region includes product sales to hospitals, physicians and distributors and is based on the final destination where the products are sold. No customers accounted for more than 10% of total product sales for the three and nine months ended September 30, 2021 or 2020. No customer accounted for more than 10% of consolidated accounts receivable as of September 30, 2021 and December 31, 2020.

Product sales by source were as follows:
Three Months Ended September 30,Nine Months Ended September 30,
Product sales by geographic location:2021202020212020
U.S.$19,354 $19,583 $57,930 $45,113 
International5,725 2,622 15,306 7,041 
Total$25,079 $22,205 $73,236 $52,154 
Three Months Ended September 30,Nine Months Ended September 30,
Product sales by category:2021202020212020
Trauma and deformity$16,817 $14,969 $49,302 $36,399 
Scoliosis7,266 6,555 20,874 14,102 
Sports medicine/other996 681 3,060 1,653 
Total$25,079 $22,205 $73,236 $52,154 
No individual country with sales originating outside of the United States accounted for more than 10% of consolidated revenue for the three and nine months ended September 30, 2021 and 2020.